Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01143714 · ClinicalTrials.gov registry record · Phase 4
A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers
A Phase 4 study of Diabetic Foot Ulcers, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 4
- Development phase
- 57
- Enrollment target
- 6
- Study locations
NCT01143714: Completed Phase 4 study of Diabetic Foot Ulcers, sponsored by Healthpoint.
NCT01143714 is a Phase 4 study of Diabetic Foot Ulcers that has completed, run by Healthpoint. The registered enrollment target is 57 participants, below the 230-participant average among 12 other Diabetic Foot Ulcers trials with a reported enrollment target (75% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01143714, a Phase 4 study of Diabetic Foot Ulcers, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 57 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to assess the effect of four weeks of treatment with Santyl Ointment, compared to White Petrolatum, on the change from baseline in wound area of diabetic foot ulcers over four weeks, and on the proportion of subjects achieving complete wound closure within 12 weeks from initiation of treatment.
Primary Outcome
The primary efficacy endpoint was the percent change in wound area from baseline to completion of the 4-week treatment phase and the 8-week follow-up period
Conditions Studied
Interventions
- DRUG Santyl
- OTHER White Petrolatum
Study Locations (6)
Pennsylvania
- The Foot and Ankle Institute of Western Pennsylvania - Pittsburgh
- Center for Advanced Wound Care - Wyomissing
California
- Olive View - UCLA Medical Center - Sylmar
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
Massachusetts
- Boston Medical Center - Boston
Texas
- Complete Family Foot Care - McAllen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
What the finished NCT01143714 record still lists
NCT01143714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 230-participant average among 12 other Diabetic Foot Ulcers trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Diabetic Foot Ulcers appearing as the primary indexed condition, and to 2 interventions - of which Santyl is the first listed.
NCT01143714 lists 6 locations in 5 states (Pennsylvania, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT01143714 about?
NCT01143714 is a clinical study titled "A Study to Look at the Effects of Four Weeks of Treatment on the Healing of Diabetic Foot Ulcers". The purpose of this study is to assess the effect of four weeks of treatment with Santyl Ointment, compared to White Petrolatum, on the change from baseline in wound area of diabetic foot ulcers over four weeks, and on the proportion of subjects achieving complete wound closure within 12 weeks from ...
What is the current status of trial NCT01143714?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 57 participants. The study started on 2010-06. Estimated completion is 2012-10.
What conditions does trial NCT01143714 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcers.
What interventions are being tested in trial NCT01143714?
The interventions under investigation include: Santyl (DRUG), White Petrolatum (OTHER).
Who is sponsoring clinical trial NCT01143714?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01143714 being conducted?
This trial has 6 study locations across California, Illinois, Massachusetts, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01143714's enrollment target sits among peer trials
57 10th of 12 higher than 3 of 12 other Diabetic Foot Ulcers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
ACTIVE NOT RECRUITING · Phase 2
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
-
Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3
COMPLETED · Phase 2
-
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
COMPLETED
-
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
COMPLETED · Phase 1
-
MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia